Mark Gergen, Executive VP, COO at Mirati Therapeutics, holds 5.75K shares in Mirati Therapeutics (Ticker: MRTX), holds ― shares in Halozyme (Ticker: HALO), holds ― shares in Poseida Therapeutics (Ticker: PSTX).

See the Hottest Stocks Based on Insider Trading >

Mark Gergen
Mirati Therapeutics (MRTX)
Executive VP, COO

Not Ranked

Mark Gergen has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

MRTX

0.00%

HALO

0.00%

PSTX

A breakdown of Mark Gergen's holdings

See the Top Stocks by Insiders

Insider Roles

Mirati Therapeutics
(MRTX)

Executive VP, COO

Halozyme
(HALO)

SVP, Chief Operating Officer

Poseida Therapeutics
(PSTX)

President and CBO, Director

Roles that Mark Gergen holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Currently, no data available

The most profitable trade made by Mark Gergen

See the Latest Stocks Traded by Insiders

Mark Gergen's Trading History

MRTX

Mirati Therapeutics

Jan 19, 2016

Executive VP, COO

Uninformative Sell

259.20K

$1.34M

HALO

Halozyme

―

SVP, Chief Operating Officer

―

PSTX

Poseida Therapeutics

―

President and CBO, Director

―

List of latest transactions for each holding click on a transaction to see Mark Gergen's performance on stock

See All Insider Trading from Today

Mark Gergen insider profile FAQ

What is the percentage of profitable transactions made by Mark Gergen?

The percentage of profitable transactions made by Mark Gergen is ―.

What is the average return per transaction made by Mark Gergen?

The average return per transaction made by Mark Gergen is ―.

What stocks does Mark Gergen hold?

Mark Gergen holds: MRTX, HALO, PSTX stocks.

What was Mark Gergen’s latest transaction?

Mark Gergen latest transaction was an Uninformative Sell of $259.20K.

What was Mark Gergen's most profitable transaction?

Mark Gergen’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.

What is Mark Gergen's role in Mirati Therapeutics?

Mark Gergen's role in Mirati Therapeutics is Executive VP, COO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Mark Gergen Insider Profile

Mark Gergen Mirati Therapeutics (MRTX)Executive VP, COO